nodes	percent_of_prediction	percent_of_DWPC	metapath
Nepafenac—PTGS1—breast cancer	0.356	0.636	CbGaD
Nepafenac—PTGS2—breast cancer	0.204	0.364	CbGaD
Nepafenac—Benzyl Benzoate—Toremifene—breast cancer	0.146	0.614	CrCrCtD
Nepafenac—Benzyl Benzoate—Tamoxifen—breast cancer	0.0918	0.386	CrCrCtD
Nepafenac—Ketorolac—PTGS1—breast cancer	0.000353	0.0601	CrCbGaD
Nepafenac—Bromfenac—PTGS1—breast cancer	0.000339	0.0576	CrCbGaD
Nepafenac—Vomiting—Toremifene—breast cancer	0.000303	0.00243	CcSEcCtD
Nepafenac—Headache—Fulvestrant—breast cancer	0.000302	0.00242	CcSEcCtD
Nepafenac—Headache—Toremifene—breast cancer	0.000298	0.00239	CcSEcCtD
Nepafenac—Pruritus—Exemestane—breast cancer	0.000297	0.00238	CcSEcCtD
Nepafenac—Dermatitis atopic—Doxorubicin—breast cancer	0.000294	0.00235	CcSEcCtD
Nepafenac—Hypersensitivity—Ixabepilone—breast cancer	0.000291	0.00234	CcSEcCtD
Nepafenac—Tiaprofenic acid—PTGS1—breast cancer	0.000288	0.049	CrCbGaD
Nepafenac—Nausea—Fulvestrant—breast cancer	0.000287	0.0023	CcSEcCtD
Nepafenac—Nausea—Toremifene—breast cancer	0.000283	0.00227	CcSEcCtD
Nepafenac—Diabetes mellitus—Capecitabine—breast cancer	0.000282	0.00226	CcSEcCtD
Nepafenac—Vision blurred—Goserelin—breast cancer	0.000281	0.00225	CcSEcCtD
Nepafenac—Pruritus—Ixabepilone—breast cancer	0.00028	0.00224	CcSEcCtD
Nepafenac—Angiopathy—Vinorelbine—breast cancer	0.000278	0.00223	CcSEcCtD
Nepafenac—Diclofenac—ABCC1—breast cancer	0.000278	0.0472	CrCbGaD
Nepafenac—Hypertension—Vinblastine—breast cancer	0.000278	0.00222	CcSEcCtD
Nepafenac—Immune system disorder—Vinorelbine—breast cancer	0.000277	0.00222	CcSEcCtD
Nepafenac—Dizziness—Exemestane—breast cancer	0.000277	0.00222	CcSEcCtD
Nepafenac—Hypersensitivity—Anastrozole—breast cancer	0.000274	0.0022	CcSEcCtD
Nepafenac—Eye disorder—Thiotepa—breast cancer	0.000274	0.00219	CcSEcCtD
Nepafenac—Eye pain—Capecitabine—breast cancer	0.000271	0.00217	CcSEcCtD
Nepafenac—Hypertension—Tamoxifen—breast cancer	0.00027	0.00216	CcSEcCtD
Nepafenac—Magnesium salicylate—PTGS1—breast cancer	0.000268	0.0455	CrCbGaD
Nepafenac—Vomiting—Exemestane—breast cancer	0.000267	0.00214	CcSEcCtD
Nepafenac—Angiopathy—Thiotepa—breast cancer	0.000266	0.00213	CcSEcCtD
Nepafenac—Immune system disorder—Thiotepa—breast cancer	0.000265	0.00212	CcSEcCtD
Nepafenac—Sinusitis—Mitoxantrone—breast cancer	0.000264	0.00212	CcSEcCtD
Nepafenac—Pruritus—Anastrozole—breast cancer	0.000263	0.00211	CcSEcCtD
Nepafenac—Pruritus—Letrozole—breast cancer	0.000263	0.00211	CcSEcCtD
Nepafenac—Headache—Exemestane—breast cancer	0.000263	0.0021	CcSEcCtD
Nepafenac—Fenbufen—PTGS1—breast cancer	0.000262	0.0446	CrCbGaD
Nepafenac—Dizziness—Ixabepilone—breast cancer	0.000262	0.0021	CcSEcCtD
Nepafenac—Hypersensitivity—Idarubicin—breast cancer	0.00026	0.00209	CcSEcCtD
Nepafenac—Dry mouth—Tamoxifen—breast cancer	0.00026	0.00208	CcSEcCtD
Nepafenac—Unspecified disorder of skin and subcutaneous tissue—Melphalan—breast cancer	0.000259	0.00207	CcSEcCtD
Nepafenac—Hypertension—Goserelin—breast cancer	0.000258	0.00206	CcSEcCtD
Nepafenac—Lacrimation increased—Epirubicin—breast cancer	0.000255	0.00204	CcSEcCtD
Nepafenac—Sinusitis—Fluorouracil—breast cancer	0.000253	0.00203	CcSEcCtD
Nepafenac—Unspecified disorder of skin and subcutaneous tissue—Goserelin—breast cancer	0.000252	0.00202	CcSEcCtD
Nepafenac—Arthritis—Capecitabine—breast cancer	0.000252	0.00202	CcSEcCtD
Nepafenac—Vomiting—Ixabepilone—breast cancer	0.000251	0.00202	CcSEcCtD
Nepafenac—Nausea—Exemestane—breast cancer	0.000249	0.002	CcSEcCtD
Nepafenac—Dry mouth—Goserelin—breast cancer	0.000248	0.00199	CcSEcCtD
Nepafenac—Headache—Ixabepilone—breast cancer	0.000248	0.00199	CcSEcCtD
Nepafenac—Gastrointestinal disorder—Chlorambucil—breast cancer	0.000247	0.00198	CcSEcCtD
Nepafenac—Dizziness—Anastrozole—breast cancer	0.000246	0.00197	CcSEcCtD
Nepafenac—Dizziness—Letrozole—breast cancer	0.000246	0.00197	CcSEcCtD
Nepafenac—Diclofenac—CXCL8—breast cancer	0.000246	0.0418	CrCbGaD
Nepafenac—Skin disorder—Melphalan—breast cancer	0.000242	0.00194	CcSEcCtD
Nepafenac—Vision blurred—Thiotepa—breast cancer	0.00024	0.00193	CcSEcCtD
Nepafenac—Nervous system disorder—Goserelin—breast cancer	0.000239	0.00191	CcSEcCtD
Nepafenac—Vomiting—Letrozole—breast cancer	0.000237	0.0019	CcSEcCtD
Nepafenac—Vomiting—Anastrozole—breast cancer	0.000237	0.0019	CcSEcCtD
Nepafenac—Skin disorder—Goserelin—breast cancer	0.000236	0.00189	CcSEcCtD
Nepafenac—Lacrimation increased—Doxorubicin—breast cancer	0.000236	0.00189	CcSEcCtD
Nepafenac—Nausea—Ixabepilone—breast cancer	0.000235	0.00188	CcSEcCtD
Nepafenac—Mebendazole—CYP1A1—breast cancer	0.000235	0.0399	CrCbGaD
Nepafenac—Dizziness—Raloxifene—breast cancer	0.000234	0.00187	CcSEcCtD
Nepafenac—Headache—Letrozole—breast cancer	0.000233	0.00187	CcSEcCtD
Nepafenac—Headache—Anastrozole—breast cancer	0.000233	0.00187	CcSEcCtD
Nepafenac—Hypertension—Vinorelbine—breast cancer	0.000231	0.00185	CcSEcCtD
Nepafenac—Angiopathy—Irinotecan—breast cancer	0.00023	0.00184	CcSEcCtD
Nepafenac—Immune system disorder—Irinotecan—breast cancer	0.000229	0.00183	CcSEcCtD
Nepafenac—Salsalate—PTGS1—breast cancer	0.000228	0.0387	CrCbGaD
Nepafenac—Unspecified disorder of skin and subcutaneous tissue—Vinorelbine—breast cancer	0.000226	0.00181	CcSEcCtD
Nepafenac—Vomiting—Idarubicin—breast cancer	0.000225	0.0018	CcSEcCtD
Nepafenac—Vomiting—Raloxifene—breast cancer	0.000225	0.0018	CcSEcCtD
Nepafenac—Angiopathy—Gemcitabine—breast cancer	0.000224	0.00179	CcSEcCtD
Nepafenac—Immune system disorder—Gemcitabine—breast cancer	0.000223	0.00178	CcSEcCtD
Nepafenac—Headache—Raloxifene—breast cancer	0.000221	0.00177	CcSEcCtD
Nepafenac—Headache—Idarubicin—breast cancer	0.000221	0.00177	CcSEcCtD
Nepafenac—Nausea—Anastrozole—breast cancer	0.000221	0.00177	CcSEcCtD
Nepafenac—Nausea—Letrozole—breast cancer	0.000221	0.00177	CcSEcCtD
Nepafenac—Hypertension—Thiotepa—breast cancer	0.00022	0.00177	CcSEcCtD
Nepafenac—Gastrointestinal disorder—Tamoxifen—breast cancer	0.00022	0.00176	CcSEcCtD
Nepafenac—Ketoprofen—CXCL8—breast cancer	0.000217	0.037	CrCbGaD
Nepafenac—Dry eye—Epirubicin—breast cancer	0.000217	0.00174	CcSEcCtD
Nepafenac—Sinusitis—Paclitaxel—breast cancer	0.000216	0.00173	CcSEcCtD
Nepafenac—Unspecified disorder of skin and subcutaneous tissue—Thiotepa—breast cancer	0.000216	0.00173	CcSEcCtD
Nepafenac—Gastrointestinal disorder—Melphalan—breast cancer	0.000215	0.00173	CcSEcCtD
Nepafenac—Nervous system disorder—Vinorelbine—breast cancer	0.000214	0.00171	CcSEcCtD
Nepafenac—Skin disorder—Vinorelbine—breast cancer	0.000212	0.0017	CcSEcCtD
Nepafenac—Hypersensitivity—Chlorambucil—breast cancer	0.000211	0.00169	CcSEcCtD
Nepafenac—Nausea—Raloxifene—breast cancer	0.00021	0.00168	CcSEcCtD
Nepafenac—Nausea—Idarubicin—breast cancer	0.00021	0.00168	CcSEcCtD
Nepafenac—Diabetes mellitus—Methotrexate—breast cancer	0.00021	0.00168	CcSEcCtD
Nepafenac—Vision blurred—Mitoxantrone—breast cancer	0.000208	0.00166	CcSEcCtD
Nepafenac—Nervous system disorder—Thiotepa—breast cancer	0.000204	0.00164	CcSEcCtD
Nepafenac—Pruritus—Chlorambucil—breast cancer	0.000203	0.00162	CcSEcCtD
Nepafenac—Skin disorder—Thiotepa—breast cancer	0.000202	0.00162	CcSEcCtD
Nepafenac—Ketorolac—PTGS2—breast cancer	0.000202	0.0343	CrCbGaD
Nepafenac—Dry eye—Doxorubicin—breast cancer	0.000201	0.00161	CcSEcCtD
Nepafenac—Vision blurred—Fluorouracil—breast cancer	0.000199	0.00159	CcSEcCtD
Nepafenac—Diabetes mellitus—Epirubicin—breast cancer	0.000196	0.00157	CcSEcCtD
Nepafenac—Bromfenac—PTGS2—breast cancer	0.000194	0.0329	CrCbGaD
Nepafenac—Hypersensitivity—Vinblastine—breast cancer	0.000193	0.00155	CcSEcCtD
Nepafenac—Eye disorder—Paclitaxel—breast cancer	0.000193	0.00155	CcSEcCtD
Nepafenac—PTGS1—nipple—breast cancer	0.000191	0.0744	CbGeAlD
Nepafenac—Hypertension—Mitoxantrone—breast cancer	0.00019	0.00152	CcSEcCtD
Nepafenac—Hypertension—Irinotecan—breast cancer	0.00019	0.00152	CcSEcCtD
Nepafenac—Eye pain—Epirubicin—breast cancer	0.000189	0.00151	CcSEcCtD
Nepafenac—Gastrointestinal disorder—Vinorelbine—breast cancer	0.000188	0.00151	CcSEcCtD
Nepafenac—Fenoprofen—PTGS1—breast cancer	0.000188	0.032	CrCbGaD
Nepafenac—Hypersensitivity—Tamoxifen—breast cancer	0.000188	0.0015	CcSEcCtD
Nepafenac—Angiopathy—Paclitaxel—breast cancer	0.000187	0.0015	CcSEcCtD
Nepafenac—Immune system disorder—Paclitaxel—breast cancer	0.000186	0.00149	CcSEcCtD
Nepafenac—Hypertension—Gemcitabine—breast cancer	0.000185	0.00148	CcSEcCtD
Nepafenac—Hypersensitivity—Melphalan—breast cancer	0.000184	0.00147	CcSEcCtD
Nepafenac—Vomiting—Chlorambucil—breast cancer	0.000182	0.00146	CcSEcCtD
Nepafenac—Diabetes mellitus—Doxorubicin—breast cancer	0.000181	0.00145	CcSEcCtD
Nepafenac—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—breast cancer	0.000181	0.00145	CcSEcCtD
Nepafenac—Pruritus—Tamoxifen—breast cancer	0.00018	0.00145	CcSEcCtD
Nepafenac—Gastrointestinal disorder—Thiotepa—breast cancer	0.00018	0.00144	CcSEcCtD
Nepafenac—Hypersensitivity—Goserelin—breast cancer	0.000179	0.00144	CcSEcCtD
Nepafenac—Pruritus—Melphalan—breast cancer	0.000177	0.00141	CcSEcCtD
Nepafenac—Nervous system disorder—Irinotecan—breast cancer	0.000176	0.00141	CcSEcCtD
Nepafenac—Eye pain—Doxorubicin—breast cancer	0.000175	0.0014	CcSEcCtD
Nepafenac—Skin disorder—Mitoxantrone—breast cancer	0.000175	0.0014	CcSEcCtD
Nepafenac—Mefenamic acid—PTGS1—breast cancer	0.000174	0.0297	CrCbGaD
Nepafenac—Dizziness—Vinblastine—breast cancer	0.000173	0.00139	CcSEcCtD
Nepafenac—Pruritus—Goserelin—breast cancer	0.000172	0.00138	CcSEcCtD
Nepafenac—Nervous system disorder—Gemcitabine—breast cancer	0.000172	0.00138	CcSEcCtD
Nepafenac—Skin disorder—Gemcitabine—breast cancer	0.00017	0.00136	CcSEcCtD
Nepafenac—Nausea—Chlorambucil—breast cancer	0.00017	0.00136	CcSEcCtD
Nepafenac—Vision blurred—Paclitaxel—breast cancer	0.000169	0.00136	CcSEcCtD
Nepafenac—Nervous system disorder—Fluorouracil—breast cancer	0.000169	0.00135	CcSEcCtD
Nepafenac—Dizziness—Tamoxifen—breast cancer	0.000169	0.00135	CcSEcCtD
Nepafenac—Vomiting—Vinblastine—breast cancer	0.000167	0.00134	CcSEcCtD
Nepafenac—Tiaprofenic acid—PTGS2—breast cancer	0.000165	0.028	CrCbGaD
Nepafenac—Headache—Vinblastine—breast cancer	0.000164	0.00132	CcSEcCtD
Nepafenac—Eye disorder—Docetaxel—breast cancer	0.000163	0.00131	CcSEcCtD
Nepafenac—Vomiting—Tamoxifen—breast cancer	0.000162	0.0013	CcSEcCtD
Nepafenac—Dizziness—Goserelin—breast cancer	0.000161	0.00129	CcSEcCtD
Nepafenac—Hypersensitivity—Vinorelbine—breast cancer	0.000161	0.00129	CcSEcCtD
Nepafenac—Headache—Tamoxifen—breast cancer	0.00016	0.00128	CcSEcCtD
Nepafenac—Angiopathy—Docetaxel—breast cancer	0.000159	0.00127	CcSEcCtD
Nepafenac—Vomiting—Melphalan—breast cancer	0.000159	0.00127	CcSEcCtD
Nepafenac—Eye disorder—Capecitabine—breast cancer	0.000158	0.00127	CcSEcCtD
Nepafenac—Immune system disorder—Docetaxel—breast cancer	0.000158	0.00127	CcSEcCtD
Nepafenac—Nausea—Vinblastine—breast cancer	0.000156	0.00125	CcSEcCtD
Nepafenac—Gastrointestinal disorder—Irinotecan—breast cancer	0.000155	0.00124	CcSEcCtD
Nepafenac—Hypertension—Paclitaxel—breast cancer	0.000155	0.00124	CcSEcCtD
Nepafenac—Vomiting—Goserelin—breast cancer	0.000155	0.00124	CcSEcCtD
Nepafenac—Pruritus—Vinorelbine—breast cancer	0.000154	0.00124	CcSEcCtD
Nepafenac—Angiopathy—Capecitabine—breast cancer	0.000154	0.00123	CcSEcCtD
Nepafenac—Hypersensitivity—Thiotepa—breast cancer	0.000153	0.00123	CcSEcCtD
Nepafenac—Immune system disorder—Capecitabine—breast cancer	0.000153	0.00123	CcSEcCtD
Nepafenac—Magnesium salicylate—PTGS2—breast cancer	0.000153	0.026	CrCbGaD
Nepafenac—Headache—Goserelin—breast cancer	0.000152	0.00122	CcSEcCtD
Nepafenac—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—breast cancer	0.000152	0.00122	CcSEcCtD
Nepafenac—Nausea—Tamoxifen—breast cancer	0.000151	0.00121	CcSEcCtD
Nepafenac—Gastrointestinal disorder—Gemcitabine—breast cancer	0.000151	0.00121	CcSEcCtD
Nepafenac—PTGS2—embryo—breast cancer	0.000151	0.0587	CbGeAlD
Nepafenac—Mebendazole—CYP3A4—breast cancer	0.00015	0.0255	CrCbGaD
Nepafenac—Fenbufen—PTGS2—breast cancer	0.00015	0.0255	CrCbGaD
Nepafenac—Dry mouth—Paclitaxel—breast cancer	0.00015	0.0012	CcSEcCtD
Nepafenac—Gastrointestinal disorder—Fluorouracil—breast cancer	0.000149	0.00119	CcSEcCtD
Nepafenac—Nausea—Melphalan—breast cancer	0.000148	0.00119	CcSEcCtD
Nepafenac—Pruritus—Thiotepa—breast cancer	0.000147	0.00118	CcSEcCtD
Nepafenac—Nausea—Goserelin—breast cancer	0.000145	0.00116	CcSEcCtD
Nepafenac—Dizziness—Vinorelbine—breast cancer	0.000144	0.00116	CcSEcCtD
Nepafenac—Nervous system disorder—Paclitaxel—breast cancer	0.000144	0.00115	CcSEcCtD
Nepafenac—Skin disorder—Paclitaxel—breast cancer	0.000142	0.00114	CcSEcCtD
Nepafenac—Vision blurred—Capecitabine—breast cancer	0.000139	0.00111	CcSEcCtD
Nepafenac—Vomiting—Vinorelbine—breast cancer	0.000139	0.00111	CcSEcCtD
Nepafenac—Dizziness—Thiotepa—breast cancer	0.000138	0.0011	CcSEcCtD
Nepafenac—Headache—Vinorelbine—breast cancer	0.000137	0.00109	CcSEcCtD
Nepafenac—Magnesium salicylate—ALB—breast cancer	0.000136	0.0232	CrCbGaD
Nepafenac—Hypersensitivity—Mitoxantrone—breast cancer	0.000132	0.00106	CcSEcCtD
Nepafenac—Hypersensitivity—Irinotecan—breast cancer	0.000132	0.00106	CcSEcCtD
Nepafenac—Vomiting—Thiotepa—breast cancer	0.000132	0.00106	CcSEcCtD
Nepafenac—Hypertension—Docetaxel—breast cancer	0.000131	0.00105	CcSEcCtD
Nepafenac—Headache—Thiotepa—breast cancer	0.00013	0.00105	CcSEcCtD
Nepafenac—Salsalate—PTGS2—breast cancer	0.00013	0.0221	CrCbGaD
Nepafenac—Nausea—Vinorelbine—breast cancer	0.00013	0.00104	CcSEcCtD
Nepafenac—PTGS1—epithelium—breast cancer	0.000129	0.0501	CbGeAlD
Nepafenac—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—breast cancer	0.000129	0.00103	CcSEcCtD
Nepafenac—Hypertension—Capecitabine—breast cancer	0.000127	0.00102	CcSEcCtD
Nepafenac—Hypersensitivity—Fluorouracil—breast cancer	0.000127	0.00102	CcSEcCtD
Nepafenac—Dry mouth—Docetaxel—breast cancer	0.000127	0.00102	CcSEcCtD
Nepafenac—Gastrointestinal disorder—Paclitaxel—breast cancer	0.000127	0.00101	CcSEcCtD
Nepafenac—Diclofenac—PTGS1—breast cancer	0.000125	0.0213	CrCbGaD
Nepafenac—Mebendazole—ABCB1—breast cancer	0.000125	0.0212	CrCbGaD
Nepafenac—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—breast cancer	0.000125	0.000999	CcSEcCtD
Nepafenac—Pruritus—Gemcitabine—breast cancer	0.000124	0.000993	CcSEcCtD
Nepafenac—Nausea—Thiotepa—breast cancer	0.000124	0.000991	CcSEcCtD
Nepafenac—Sinusitis—Epirubicin—breast cancer	0.000123	0.000988	CcSEcCtD
Nepafenac—PTGS2—epithelium—breast cancer	0.000123	0.0479	CbGeAlD
Nepafenac—Dry mouth—Capecitabine—breast cancer	0.000123	0.000984	CcSEcCtD
Nepafenac—PTGS1—skin of body—breast cancer	0.000123	0.0477	CbGeAlD
Nepafenac—Nervous system disorder—Docetaxel—breast cancer	0.000122	0.000977	CcSEcCtD
Nepafenac—Pruritus—Fluorouracil—breast cancer	0.000122	0.000976	CcSEcCtD
Nepafenac—Skin disorder—Docetaxel—breast cancer	0.000121	0.000968	CcSEcCtD
Nepafenac—Dizziness—Irinotecan—breast cancer	0.000119	0.000953	CcSEcCtD
Nepafenac—Nervous system disorder—Capecitabine—breast cancer	0.000118	0.000946	CcSEcCtD
Nepafenac—Eye disorder—Methotrexate—breast cancer	0.000118	0.000944	CcSEcCtD
Nepafenac—PTGS2—skin of body—breast cancer	0.000117	0.0456	CbGeAlD
Nepafenac—Skin disorder—Capecitabine—breast cancer	0.000117	0.000937	CcSEcCtD
Nepafenac—PTGS1—endometrium—breast cancer	0.000116	0.045	CbGeAlD
Nepafenac—Diclofenac—CYP1A1—breast cancer	0.000115	0.0195	CrCbGaD
Nepafenac—Angiopathy—Methotrexate—breast cancer	0.000114	0.000917	CcSEcCtD
Nepafenac—Vomiting—Irinotecan—breast cancer	0.000114	0.000916	CcSEcCtD
Nepafenac—Vomiting—Mitoxantrone—breast cancer	0.000114	0.000916	CcSEcCtD
Nepafenac—Sinusitis—Doxorubicin—breast cancer	0.000114	0.000915	CcSEcCtD
Nepafenac—Immune system disorder—Methotrexate—breast cancer	0.000114	0.000913	CcSEcCtD
Nepafenac—Dizziness—Fluorouracil—breast cancer	0.000114	0.000913	CcSEcCtD
Nepafenac—Headache—Mitoxantrone—breast cancer	0.000113	0.000903	CcSEcCtD
Nepafenac—Headache—Irinotecan—breast cancer	0.000113	0.000903	CcSEcCtD
Nepafenac—Vomiting—Gemcitabine—breast cancer	0.000111	0.000893	CcSEcCtD
Nepafenac—Ketoprofen—PTGS1—breast cancer	0.000111	0.0189	CrCbGaD
Nepafenac—PTGS2—endometrium—breast cancer	0.00011	0.043	CbGeAlD
Nepafenac—Eye disorder—Epirubicin—breast cancer	0.00011	0.000884	CcSEcCtD
Nepafenac—Headache—Gemcitabine—breast cancer	0.00011	0.000879	CcSEcCtD
Nepafenac—Vomiting—Fluorouracil—breast cancer	0.000109	0.000878	CcSEcCtD
Nepafenac—Hypersensitivity—Paclitaxel—breast cancer	0.000108	0.000866	CcSEcCtD
Nepafenac—Headache—Fluorouracil—breast cancer	0.000108	0.000865	CcSEcCtD
Nepafenac—Fenoprofen—PTGS2—breast cancer	0.000107	0.0183	CrCbGaD
Nepafenac—Gastrointestinal disorder—Docetaxel—breast cancer	0.000107	0.00086	CcSEcCtD
Nepafenac—Angiopathy—Epirubicin—breast cancer	0.000107	0.000858	CcSEcCtD
Nepafenac—Nausea—Irinotecan—breast cancer	0.000107	0.000856	CcSEcCtD
Nepafenac—Nausea—Mitoxantrone—breast cancer	0.000107	0.000856	CcSEcCtD
Nepafenac—Immune system disorder—Epirubicin—breast cancer	0.000107	0.000854	CcSEcCtD
Nepafenac—PTGS1—uterus—breast cancer	0.000106	0.0414	CbGeAlD
Nepafenac—PTGS1—pituitary gland—breast cancer	0.000105	0.0407	CbGeAlD
Nepafenac—PTGS1—adipose tissue—breast cancer	0.000104	0.0405	CbGeAlD
Nepafenac—Nausea—Gemcitabine—breast cancer	0.000104	0.000834	CcSEcCtD
Nepafenac—Gastrointestinal disorder—Capecitabine—breast cancer	0.000104	0.000833	CcSEcCtD
Nepafenac—Pruritus—Paclitaxel—breast cancer	0.000104	0.000831	CcSEcCtD
Nepafenac—Vision blurred—Methotrexate—breast cancer	0.000103	0.000829	CcSEcCtD
Nepafenac—Nausea—Fluorouracil—breast cancer	0.000102	0.00082	CcSEcCtD
Nepafenac—Eye disorder—Doxorubicin—breast cancer	0.000102	0.000818	CcSEcCtD
Nepafenac—PTGS2—uterus—breast cancer	0.000102	0.0396	CbGeAlD
Nepafenac—PTGS2—pituitary gland—breast cancer	9.99e-05	0.0389	CbGeAlD
Nepafenac—Mefenamic acid—PTGS2—breast cancer	9.97e-05	0.017	CrCbGaD
Nepafenac—PTGS2—adipose tissue—breast cancer	9.95e-05	0.0387	CbGeAlD
Nepafenac—Angiopathy—Doxorubicin—breast cancer	9.91e-05	0.000794	CcSEcCtD
Nepafenac—Immune system disorder—Doxorubicin—breast cancer	9.86e-05	0.00079	CcSEcCtD
Nepafenac—Dizziness—Paclitaxel—breast cancer	9.7e-05	0.000777	CcSEcCtD
Nepafenac—Vision blurred—Epirubicin—breast cancer	9.68e-05	0.000776	CcSEcCtD
Nepafenac—Fenoprofen—ALB—breast cancer	9.58e-05	0.0163	CrCbGaD
Nepafenac—PTGS1—female reproductive system—breast cancer	9.57e-05	0.0372	CbGeAlD
Nepafenac—PTGS1—adrenal gland—breast cancer	9.34e-05	0.0363	CbGeAlD
Nepafenac—Vomiting—Paclitaxel—breast cancer	9.32e-05	0.000747	CcSEcCtD
Nepafenac—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	9.28e-05	0.000744	CcSEcCtD
Nepafenac—Oxcarbazepine—CYP3A4—breast cancer	9.21e-05	0.0157	CrCbGaD
Nepafenac—Headache—Paclitaxel—breast cancer	9.19e-05	0.000736	CcSEcCtD
Nepafenac—Hypersensitivity—Docetaxel—breast cancer	9.16e-05	0.000734	CcSEcCtD
Nepafenac—PTGS2—female reproductive system—breast cancer	9.15e-05	0.0356	CbGeAlD
Nepafenac—Vision blurred—Doxorubicin—breast cancer	8.96e-05	0.000718	CcSEcCtD
Nepafenac—PTGS2—adrenal gland—breast cancer	8.93e-05	0.0347	CbGeAlD
Nepafenac—Hypertension—Epirubicin—breast cancer	8.87e-05	0.000711	CcSEcCtD
Nepafenac—Hypersensitivity—Capecitabine—breast cancer	8.87e-05	0.000711	CcSEcCtD
Nepafenac—Pruritus—Docetaxel—breast cancer	8.79e-05	0.000705	CcSEcCtD
Nepafenac—Nervous system disorder—Methotrexate—breast cancer	8.79e-05	0.000704	CcSEcCtD
Nepafenac—Nausea—Paclitaxel—breast cancer	8.71e-05	0.000698	CcSEcCtD
Nepafenac—PTGS1—female gonad—breast cancer	8.71e-05	0.0339	CbGeAlD
Nepafenac—Skin disorder—Methotrexate—breast cancer	8.7e-05	0.000697	CcSEcCtD
Nepafenac—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	8.69e-05	0.000696	CcSEcCtD
Nepafenac—PTGS2—bone marrow—breast cancer	8.64e-05	0.0336	CbGeAlD
Nepafenac—Dry mouth—Epirubicin—breast cancer	8.55e-05	0.000685	CcSEcCtD
Nepafenac—Pruritus—Capecitabine—breast cancer	8.51e-05	0.000682	CcSEcCtD
Nepafenac—PTGS2—female gonad—breast cancer	8.33e-05	0.0324	CbGeAlD
Nepafenac—Nervous system disorder—Epirubicin—breast cancer	8.22e-05	0.000659	CcSEcCtD
Nepafenac—Dizziness—Docetaxel—breast cancer	8.22e-05	0.000659	CcSEcCtD
Nepafenac—Hypertension—Doxorubicin—breast cancer	8.21e-05	0.000658	CcSEcCtD
Nepafenac—Skin disorder—Epirubicin—breast cancer	8.14e-05	0.000653	CcSEcCtD
Nepafenac—PTGS1—endocrine gland—breast cancer	8.1e-05	0.0315	CbGeAlD
Nepafenac—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	8.04e-05	0.000644	CcSEcCtD
Nepafenac—Oxcarbazepine—ALB—breast cancer	8.03e-05	0.0137	CrCbGaD
Nepafenac—Dizziness—Capecitabine—breast cancer	7.96e-05	0.000638	CcSEcCtD
Nepafenac—Dry mouth—Doxorubicin—breast cancer	7.91e-05	0.000634	CcSEcCtD
Nepafenac—Vomiting—Docetaxel—breast cancer	7.9e-05	0.000633	CcSEcCtD
Nepafenac—Headache—Docetaxel—breast cancer	7.79e-05	0.000624	CcSEcCtD
Nepafenac—PTGS2—endocrine gland—breast cancer	7.74e-05	0.0301	CbGeAlD
Nepafenac—Gastrointestinal disorder—Methotrexate—breast cancer	7.73e-05	0.00062	CcSEcCtD
Nepafenac—Vomiting—Capecitabine—breast cancer	7.65e-05	0.000613	CcSEcCtD
Nepafenac—Nervous system disorder—Doxorubicin—breast cancer	7.61e-05	0.00061	CcSEcCtD
Nepafenac—Headache—Capecitabine—breast cancer	7.54e-05	0.000604	CcSEcCtD
Nepafenac—Skin disorder—Doxorubicin—breast cancer	7.53e-05	0.000604	CcSEcCtD
Nepafenac—Nausea—Docetaxel—breast cancer	7.38e-05	0.000592	CcSEcCtD
Nepafenac—Diclofenac—CYP3A4—breast cancer	7.32e-05	0.0124	CrCbGaD
Nepafenac—Gastrointestinal disorder—Epirubicin—breast cancer	7.24e-05	0.00058	CcSEcCtD
Nepafenac—Diclofenac—PTGS2—breast cancer	7.16e-05	0.0122	CrCbGaD
Nepafenac—Nausea—Capecitabine—breast cancer	7.15e-05	0.000573	CcSEcCtD
Nepafenac—Modafinil—CYP3A4—breast cancer	6.88e-05	0.0117	CrCbGaD
Nepafenac—Gastrointestinal disorder—Doxorubicin—breast cancer	6.7e-05	0.000537	CcSEcCtD
Nepafenac—Hypersensitivity—Methotrexate—breast cancer	6.6e-05	0.000529	CcSEcCtD
Nepafenac—Diclofenac—ALB—breast cancer	6.38e-05	0.0109	CrCbGaD
Nepafenac—Ketoprofen—PTGS2—breast cancer	6.34e-05	0.0108	CrCbGaD
Nepafenac—Pruritus—Methotrexate—breast cancer	6.34e-05	0.000508	CcSEcCtD
Nepafenac—Carbamazepine—CYP3A4—breast cancer	6.28e-05	0.0107	CrCbGaD
Nepafenac—Hypersensitivity—Epirubicin—breast cancer	6.18e-05	0.000495	CcSEcCtD
Nepafenac—Diclofenac—ABCB1—breast cancer	6.09e-05	0.0104	CrCbGaD
Nepafenac—Pruritus—Epirubicin—breast cancer	5.93e-05	0.000475	CcSEcCtD
Nepafenac—Dizziness—Methotrexate—breast cancer	5.92e-05	0.000475	CcSEcCtD
Nepafenac—Hypersensitivity—Doxorubicin—breast cancer	5.72e-05	0.000458	CcSEcCtD
Nepafenac—Vomiting—Methotrexate—breast cancer	5.7e-05	0.000456	CcSEcCtD
Nepafenac—Ketoprofen—ALB—breast cancer	5.65e-05	0.00962	CrCbGaD
Nepafenac—Headache—Methotrexate—breast cancer	5.61e-05	0.00045	CcSEcCtD
Nepafenac—PTGS1—lymph node—breast cancer	5.6e-05	0.0218	CbGeAlD
Nepafenac—Dizziness—Epirubicin—breast cancer	5.54e-05	0.000444	CcSEcCtD
Nepafenac—Pruritus—Doxorubicin—breast cancer	5.49e-05	0.00044	CcSEcCtD
Nepafenac—PTGS2—lymph node—breast cancer	5.35e-05	0.0208	CbGeAlD
Nepafenac—Vomiting—Epirubicin—breast cancer	5.33e-05	0.000427	CcSEcCtD
Nepafenac—Nausea—Methotrexate—breast cancer	5.32e-05	0.000426	CcSEcCtD
Nepafenac—Headache—Epirubicin—breast cancer	5.25e-05	0.000421	CcSEcCtD
Nepafenac—Carbamazepine—ABCB1—breast cancer	5.22e-05	0.00889	CrCbGaD
Nepafenac—Dizziness—Doxorubicin—breast cancer	5.13e-05	0.000411	CcSEcCtD
Nepafenac—Nausea—Epirubicin—breast cancer	4.98e-05	0.000399	CcSEcCtD
Nepafenac—Vomiting—Doxorubicin—breast cancer	4.93e-05	0.000395	CcSEcCtD
Nepafenac—Headache—Doxorubicin—breast cancer	4.86e-05	0.000389	CcSEcCtD
Nepafenac—Nausea—Doxorubicin—breast cancer	4.61e-05	0.000369	CcSEcCtD
Nepafenac—PTGS1—Metabolism—GPX2—breast cancer	3.08e-05	0.00045	CbGpPWpGaD
Nepafenac—PTGS2—Disease—ELL—breast cancer	3.08e-05	0.00045	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—ALDH7A1—breast cancer	3.08e-05	0.00045	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—ALDH1A1—breast cancer	3.08e-05	0.00045	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—TP53—breast cancer	3.06e-05	0.000446	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1A—breast cancer	3.06e-05	0.000446	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—breast cancer	3.05e-05	0.000445	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—GPX4—breast cancer	3.05e-05	0.000444	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—SULT1A1—breast cancer	3.05e-05	0.000444	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—CYP19A1—breast cancer	3.05e-05	0.000444	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK8—breast cancer	2.98e-05	0.000435	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—IDH1—breast cancer	2.97e-05	0.000434	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—GSTA1—breast cancer	2.97e-05	0.000434	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—UMPS—breast cancer	2.95e-05	0.000431	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—ADSL—breast cancer	2.95e-05	0.000431	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—PHGDH—breast cancer	2.95e-05	0.000431	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—NME1—breast cancer	2.95e-05	0.000431	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—FHL2—breast cancer	2.95e-05	0.000431	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—NAT2—breast cancer	2.94e-05	0.000429	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—LDHB—breast cancer	2.9e-05	0.000423	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—BRIP1—breast cancer	2.9e-05	0.000423	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—HPSE—breast cancer	2.9e-05	0.000423	CbGpPWpGaD
Nepafenac—PTGS2—Disease—HEY2—breast cancer	2.89e-05	0.000421	CbGpPWpGaD
Nepafenac—PTGS2—Disease—RPS6KB2—breast cancer	2.85e-05	0.000416	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—SRC—breast cancer	2.83e-05	0.000413	CbGpPWpGaD
Nepafenac—PTGS2—Disease—IDH1—breast cancer	2.82e-05	0.000411	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—IL6—breast cancer	2.8e-05	0.000409	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—breast cancer	2.75e-05	0.000402	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—GSTA3—breast cancer	2.75e-05	0.000401	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—HMMR—breast cancer	2.75e-05	0.000401	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—ABCC1—breast cancer	2.75e-05	0.000401	CbGpPWpGaD
Nepafenac—PTGS2—Disease—TLE3—breast cancer	2.7e-05	0.000394	CbGpPWpGaD
Nepafenac—PTGS2—Disease—HEY1—breast cancer	2.67e-05	0.00039	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—PPARGC1B—breast cancer	2.66e-05	0.000388	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—CAV1—breast cancer	2.66e-05	0.000388	CbGpPWpGaD
Nepafenac—PTGS2—Disease—DLL1—breast cancer	2.62e-05	0.000382	CbGpPWpGaD
Nepafenac—PTGS2—Disease—RPL23A—breast cancer	2.62e-05	0.000382	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK3—breast cancer	2.61e-05	0.00038	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—PLA2G4A—breast cancer	2.59e-05	0.000378	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—NCOR1—breast cancer	2.59e-05	0.000378	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—MED12—breast cancer	2.58e-05	0.000376	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—DPYD—breast cancer	2.58e-05	0.000376	CbGpPWpGaD
Nepafenac—PTGS2—Disease—HIST1H2BK—breast cancer	2.57e-05	0.000375	CbGpPWpGaD
Nepafenac—PTGS2—Disease—MAP2K7—breast cancer	2.57e-05	0.000375	CbGpPWpGaD
Nepafenac—PTGS2—Disease—HIST1H2BC—breast cancer	2.57e-05	0.000375	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—ALDOA—breast cancer	2.54e-05	0.00037	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—breast cancer	2.53e-05	0.00037	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—breast cancer	2.53e-05	0.000369	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—GSTA4—breast cancer	2.51e-05	0.000366	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—CA9—breast cancer	2.51e-05	0.000366	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—GPX1—breast cancer	2.48e-05	0.000362	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—breast cancer	2.48e-05	0.000362	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—NCOA3—breast cancer	2.46e-05	0.00036	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—CYP1A1—breast cancer	2.45e-05	0.000358	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—GPX2—breast cancer	2.45e-05	0.000357	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—GSTA2—breast cancer	2.45e-05	0.000357	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—SLC2A2—breast cancer	2.45e-05	0.000357	CbGpPWpGaD
Nepafenac—PTGS2—Disease—RPS7—breast cancer	2.44e-05	0.000357	CbGpPWpGaD
Nepafenac—PTGS2—Disease—RPS8—breast cancer	2.44e-05	0.000357	CbGpPWpGaD
Nepafenac—PTGS2—Disease—DKK1—breast cancer	2.43e-05	0.000354	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	2.42e-05	0.000353	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—GPX4—breast cancer	2.42e-05	0.000353	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—SULT1A1—breast cancer	2.42e-05	0.000353	CbGpPWpGaD
Nepafenac—PTGS2—Disease—ALDOA—breast cancer	2.41e-05	0.000351	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—ABCG2—breast cancer	2.4e-05	0.00035	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—CPT1A—breast cancer	2.4e-05	0.00035	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—MTR—breast cancer	2.4e-05	0.00035	CbGpPWpGaD
Nepafenac—PTGS2—Disease—JAG2—breast cancer	2.37e-05	0.000346	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—GSTA1—breast cancer	2.36e-05	0.000345	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—IDH1—breast cancer	2.36e-05	0.000345	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—breast cancer	2.36e-05	0.000344	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—HPGDS—breast cancer	2.35e-05	0.000343	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—breast cancer	2.34e-05	0.000342	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—HBA1—breast cancer	2.34e-05	0.000341	CbGpPWpGaD
Nepafenac—PTGS2—Disease—WNT1—breast cancer	2.34e-05	0.000341	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—NAT2—breast cancer	2.34e-05	0.000341	CbGpPWpGaD
Nepafenac—PTGS2—Disease—SLC2A2—breast cancer	2.32e-05	0.000339	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—GSTT1—breast cancer	2.28e-05	0.000333	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—ACHE—breast cancer	2.28e-05	0.000333	CbGpPWpGaD
Nepafenac—PTGS2—Disease—MTR—breast cancer	2.27e-05	0.000332	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—CYP17A1—breast cancer	2.16e-05	0.000315	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—breast cancer	2.15e-05	0.000314	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—ENO1—breast cancer	2.14e-05	0.000312	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	2.13e-05	0.000311	CbGpPWpGaD
Nepafenac—PTGS2—Disease—HSPA1B—breast cancer	2.11e-05	0.000308	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—CAV1—breast cancer	2.11e-05	0.000308	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—ALB—breast cancer	2.1e-05	0.000307	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—CYP2D6—breast cancer	2.1e-05	0.000306	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—breast cancer	2.08e-05	0.000304	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—NCOA2—breast cancer	2.06e-05	0.0003	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—MED12—breast cancer	2.05e-05	0.000299	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—DPYD—breast cancer	2.05e-05	0.000299	CbGpPWpGaD
Nepafenac—PTGS2—Disease—ENO1—breast cancer	2.03e-05	0.000296	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—ALDOA—breast cancer	2.02e-05	0.000294	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—FASN—breast cancer	2e-05	0.000291	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—BCHE—breast cancer	1.99e-05	0.00029	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—SLC5A5—breast cancer	1.96e-05	0.000286	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—NCOA3—breast cancer	1.96e-05	0.000286	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—SLC2A2—breast cancer	1.94e-05	0.000283	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	1.92e-05	0.000281	CbGpPWpGaD
Nepafenac—PTGS2—Disease—FGF3—breast cancer	1.92e-05	0.00028	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—CPT1A—breast cancer	1.9e-05	0.000278	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—MTR—breast cancer	1.9e-05	0.000278	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—ABCG2—breast cancer	1.9e-05	0.000278	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—NQO1—breast cancer	1.9e-05	0.000277	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—SLC2A1—breast cancer	1.9e-05	0.000277	CbGpPWpGaD
Nepafenac—PTGS2—Disease—JAG1—breast cancer	1.89e-05	0.000276	CbGpPWpGaD
Nepafenac—PTGS2—Disease—FASN—breast cancer	1.89e-05	0.000276	CbGpPWpGaD
Nepafenac—PTGS2—Disease—PARP1—breast cancer	1.88e-05	0.000275	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—HPGDS—breast cancer	1.87e-05	0.000272	CbGpPWpGaD
Nepafenac—PTGS2—Disease—CALCA—breast cancer	1.86e-05	0.000271	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	1.86e-05	0.000271	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—HBA1—breast cancer	1.85e-05	0.000271	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—CYP3A4—breast cancer	1.85e-05	0.00027	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	1.84e-05	0.000268	CbGpPWpGaD
Nepafenac—PTGS2—Disease—RPS6—breast cancer	1.84e-05	0.000268	CbGpPWpGaD
Nepafenac—PTGS2—Disease—FGF4—breast cancer	1.82e-05	0.000266	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—CYP1B1—breast cancer	1.82e-05	0.000265	CbGpPWpGaD
Nepafenac—PTGS2—Disease—CXCR4—breast cancer	1.82e-05	0.000265	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—GSTT1—breast cancer	1.81e-05	0.000264	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—ACHE—breast cancer	1.81e-05	0.000264	CbGpPWpGaD
Nepafenac—PTGS2—Disease—SLC2A1—breast cancer	1.8e-05	0.000262	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—HSP90AA1—breast cancer	1.78e-05	0.00026	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—breast cancer	1.76e-05	0.000256	CbGpPWpGaD
Nepafenac—PTGS2—Disease—TCF7L2—breast cancer	1.75e-05	0.000256	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—NCOA1—breast cancer	1.73e-05	0.000253	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—CYP17A1—breast cancer	1.71e-05	0.00025	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—STK11—breast cancer	1.71e-05	0.000249	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—CYP19A1—breast cancer	1.71e-05	0.000249	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—PTGS1—breast cancer	1.7e-05	0.000248	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—ENO1—breast cancer	1.7e-05	0.000248	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	1.69e-05	0.000247	CbGpPWpGaD
Nepafenac—PTGS2—Disease—HSP90AA1—breast cancer	1.69e-05	0.000246	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—ALB—breast cancer	1.67e-05	0.000243	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—CYP2D6—breast cancer	1.66e-05	0.000243	CbGpPWpGaD
Nepafenac—PTGS2—Disease—PRL—breast cancer	1.64e-05	0.00024	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—NCOA2—breast cancer	1.63e-05	0.000238	CbGpPWpGaD
Nepafenac—PTGS2—Disease—ADAM10—breast cancer	1.62e-05	0.000236	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—PTEN—breast cancer	1.6e-05	0.000234	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—COMT—breast cancer	1.59e-05	0.000232	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—FASN—breast cancer	1.58e-05	0.000231	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—GSTP1—breast cancer	1.58e-05	0.000231	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—BCHE—breast cancer	1.58e-05	0.00023	CbGpPWpGaD
Nepafenac—PTGS2—Disease—FGF10—breast cancer	1.58e-05	0.00023	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—HMOX1—breast cancer	1.56e-05	0.000227	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—SLC5A5—breast cancer	1.56e-05	0.000227	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—ITPR1—breast cancer	1.56e-05	0.000227	CbGpPWpGaD
Nepafenac—PTGS2—Disease—PDGFA—breast cancer	1.52e-05	0.000222	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—NQO1—breast cancer	1.5e-05	0.00022	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—SLC2A1—breast cancer	1.5e-05	0.00022	CbGpPWpGaD
Nepafenac—PTGS2—Disease—TGFBR2—breast cancer	1.5e-05	0.000219	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—ABCB1—breast cancer	1.5e-05	0.000218	CbGpPWpGaD
Nepafenac—PTGS2—Disease—ITPR1—breast cancer	1.47e-05	0.000215	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	1.47e-05	0.000215	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—TYMS—breast cancer	1.47e-05	0.000214	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—CYP3A4—breast cancer	1.47e-05	0.000214	CbGpPWpGaD
Nepafenac—PTGS2—Disease—ERBB4—breast cancer	1.46e-05	0.000214	CbGpPWpGaD
Nepafenac—PTGS2—Disease—STAT5A—breast cancer	1.46e-05	0.000214	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—PLA2G4A—breast cancer	1.45e-05	0.000212	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—GSTM1—breast cancer	1.45e-05	0.000212	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—NCOR1—breast cancer	1.45e-05	0.000212	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—CYP1B1—breast cancer	1.44e-05	0.00021	CbGpPWpGaD
Nepafenac—PTGS2—Disease—SMAD4—breast cancer	1.42e-05	0.000207	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—HSP90AA1—breast cancer	1.41e-05	0.000206	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—GPX1—breast cancer	1.39e-05	0.000203	CbGpPWpGaD
Nepafenac—PTGS2—Disease—HES1—breast cancer	1.39e-05	0.000202	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—CYP1A1—breast cancer	1.38e-05	0.000201	CbGpPWpGaD
Nepafenac—PTGS2—Disease—NCOR1—breast cancer	1.38e-05	0.000201	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—NCOA1—breast cancer	1.38e-05	0.000201	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—ERCC2—breast cancer	1.37e-05	0.000199	CbGpPWpGaD
Nepafenac—PTGS2—Disease—FGF1—breast cancer	1.36e-05	0.000199	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—STK11—breast cancer	1.36e-05	0.000198	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—CYP19A1—breast cancer	1.36e-05	0.000198	CbGpPWpGaD
Nepafenac—PTGS2—Disease—NRG1—breast cancer	1.35e-05	0.000197	CbGpPWpGaD
Nepafenac—PTGS2—Disease—H2AFX—breast cancer	1.34e-05	0.000196	CbGpPWpGaD
Nepafenac—PTGS2—Disease—ERCC2—breast cancer	1.29e-05	0.000189	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—MTHFR—breast cancer	1.28e-05	0.000187	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—PTEN—breast cancer	1.27e-05	0.000186	CbGpPWpGaD
Nepafenac—PTGS2—Disease—ERBB3—breast cancer	1.27e-05	0.000185	CbGpPWpGaD
Nepafenac—PTGS2—Disease—FGFR2—breast cancer	1.26e-05	0.000184	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—COMT—breast cancer	1.26e-05	0.000184	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—GSTP1—breast cancer	1.25e-05	0.000183	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—HMOX1—breast cancer	1.24e-05	0.000181	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—ITPR1—breast cancer	1.23e-05	0.00018	CbGpPWpGaD
Nepafenac—PTGS2—Disease—MTHFR—breast cancer	1.22e-05	0.000178	CbGpPWpGaD
Nepafenac—PTGS2—Disease—TERT—breast cancer	1.21e-05	0.000177	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—ABCB1—breast cancer	1.19e-05	0.000173	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—CAV1—breast cancer	1.18e-05	0.000173	CbGpPWpGaD
Nepafenac—PTGS2—Disease—FGFR1—breast cancer	1.18e-05	0.000172	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—TYMS—breast cancer	1.17e-05	0.00017	CbGpPWpGaD
Nepafenac—PTGS2—Disease—HIF1A—breast cancer	1.16e-05	0.000169	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—PLA2G4A—breast cancer	1.15e-05	0.000168	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—NCOR1—breast cancer	1.15e-05	0.000168	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—GSTM1—breast cancer	1.15e-05	0.000168	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.13e-05	0.000165	CbGpPWpGaD
Nepafenac—PTGS2—Disease—CAV1—breast cancer	1.12e-05	0.000164	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—GPX1—breast cancer	1.1e-05	0.000161	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—CYP1A1—breast cancer	1.09e-05	0.00016	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—ERCC2—breast cancer	1.08e-05	0.000158	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—PIK3CG—breast cancer	1.08e-05	0.000157	CbGpPWpGaD
Nepafenac—PTGS2—Disease—NOS2—breast cancer	1.06e-05	0.000154	CbGpPWpGaD
Nepafenac—PTGS2—Disease—NOTCH1—breast cancer	1.05e-05	0.000153	CbGpPWpGaD
Nepafenac—PTGS2—Disease—KIT—breast cancer	1.02e-05	0.000149	CbGpPWpGaD
Nepafenac—PTGS2—Disease—APC—breast cancer	1.02e-05	0.000149	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—MTHFR—breast cancer	1.02e-05	0.000149	CbGpPWpGaD
Nepafenac—PTGS2—Disease—EGF—breast cancer	1.01e-05	0.000147	CbGpPWpGaD
Nepafenac—PTGS2—Disease—BRAF—breast cancer	9.61e-06	0.00014	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—PIK3CD—breast cancer	9.48e-06	0.000138	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—CAV1—breast cancer	9.4e-06	0.000137	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—ALB—breast cancer	9.36e-06	0.000137	CbGpPWpGaD
Nepafenac—PTGS2—Disease—AKT2—breast cancer	9.36e-06	0.000137	CbGpPWpGaD
Nepafenac—PTGS2—Disease—PIK3CD—breast cancer	8.99e-06	0.000131	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	8.98e-06	0.000131	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—NOS3—breast cancer	8.95e-06	0.000131	CbGpPWpGaD
Nepafenac—PTGS2—Disease—SERPINE1—breast cancer	8.89e-06	0.00013	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—PIK3CG—breast cancer	8.56e-06	0.000125	CbGpPWpGaD
Nepafenac—PTGS2—Disease—NOS3—breast cancer	8.49e-06	0.000124	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—PIK3CB—breast cancer	8.27e-06	0.000121	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—PTGS2—breast cancer	8.19e-06	0.000119	CbGpPWpGaD
Nepafenac—PTGS2—Disease—MDM2—breast cancer	8.05e-06	0.000117	CbGpPWpGaD
Nepafenac—PTGS2—Disease—RAF1—breast cancer	8.03e-06	0.000117	CbGpPWpGaD
Nepafenac—PTGS2—Disease—ERBB2—breast cancer	7.94e-06	0.000116	CbGpPWpGaD
Nepafenac—PTGS2—Disease—PIK3CB—breast cancer	7.84e-06	0.000114	CbGpPWpGaD
Nepafenac—PTGS2—Disease—MTOR—breast cancer	7.84e-06	0.000114	CbGpPWpGaD
Nepafenac—PTGS2—Disease—CD4—breast cancer	7.82e-06	0.000114	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—PIK3CD—breast cancer	7.53e-06	0.00011	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—ALB—breast cancer	7.43e-06	0.000108	CbGpPWpGaD
Nepafenac—PTGS2—Disease—CDKN1B—breast cancer	7.35e-06	0.000107	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—PTEN—breast cancer	7.14e-06	0.000104	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—NOS3—breast cancer	7.11e-06	0.000104	CbGpPWpGaD
Nepafenac—PTGS2—Disease—CTNNB1—breast cancer	6.95e-06	0.000101	CbGpPWpGaD
Nepafenac—PTGS2—Disease—CDKN1A—breast cancer	6.79e-06	9.9e-05	CbGpPWpGaD
Nepafenac—PTGS2—Disease—PTEN—breast cancer	6.77e-06	9.88e-05	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—PIK3CB—breast cancer	6.56e-06	9.57e-05	CbGpPWpGaD
Nepafenac—PTGS2—Disease—SRC—breast cancer	6.28e-06	9.16e-05	CbGpPWpGaD
Nepafenac—PTGS2—Disease—STAT3—breast cancer	6.06e-06	8.83e-05	CbGpPWpGaD
Nepafenac—PTGS2—Disease—MAPK3—breast cancer	5.78e-06	8.44e-05	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—PTEN—breast cancer	5.67e-06	8.27e-05	CbGpPWpGaD
Nepafenac—PTGS2—Disease—MYC—breast cancer	5.63e-06	8.21e-05	CbGpPWpGaD
Nepafenac—PTGS2—Disease—TGFB1—breast cancer	5.61e-06	8.19e-05	CbGpPWpGaD
Nepafenac—PTGS2—Disease—EGFR—breast cancer	5.5e-06	8.03e-05	CbGpPWpGaD
Nepafenac—PTGS2—Disease—KRAS—breast cancer	5.2e-06	7.59e-05	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—PIK3CA—breast cancer	5.04e-06	7.35e-05	CbGpPWpGaD
Nepafenac—PTGS2—Disease—PIK3CA—breast cancer	4.78e-06	6.97e-05	CbGpPWpGaD
Nepafenac—PTGS2—Disease—HRAS—breast cancer	4.42e-06	6.45e-05	CbGpPWpGaD
Nepafenac—PTGS2—Disease—IL6—breast cancer	4.23e-06	6.17e-05	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—AKT1—breast cancer	4.12e-06	6.01e-05	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—PIK3CA—breast cancer	4e-06	5.84e-05	CbGpPWpGaD
Nepafenac—PTGS2—Disease—AKT1—breast cancer	3.9e-06	5.69e-05	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—AKT1—breast cancer	3.27e-06	4.77e-05	CbGpPWpGaD
